Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-17

Clinical Trial Update: Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating whether periostin biomarker guidance can safely allow withdrawal of inhaled corticosteroids in patients with non-eosinophilic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Asthma | Phase 4 | Status: COMPLETED